anti-il5 and anti-ige biologic classes in patients with severe asthma eligible for both
Published 1 year ago • 577 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
24:38
uncontrolled, moderate to severe asthma: identifying eligible patients for targeted biologic therapy
-
3:55
anti il5 and indicators for use
-
35:12
role of ige inhibitors in severe allergic asthma
-
55:26
biologics for asthma and allergy (aljubran)
-
4:27
treating asthma using biologic therapy
-
53:47
use of biologics in asthma and other allergic disorders (aljubran)
-
1:07:06
examination of upstream biologics in severe asthma: live cme exam room with drs. blaiss & wechsler!
-
0:16
what are the side effects of biologic medications for asthma and allergies?
-
55:53
severe therapy-resistant asthma: dr louise fleming | paech teaching for trainees
-
27:11
advances in allergy and clinical immunology
-
1:01:34
asthma guideline series part 2
-
21:29
immunomodulators: biologics for the treatment of food allergy | 2020 research retreat
-
22:37
severe asthma and biologics: a simplified way of understanding
-
41:07
1/15/21 biologics in asthma - dr. misiak
-
51:52
the asthma yardstick: what it means to practitioners and patients
-
45:02
management of severe asthma (bacharier)
-
31:42
expert insights on the rationale for targeting epithelial alarmins in severe asthma
-
7:53
allergic asthma lecture 6